Randomized trial of influence of vitamin D on the prevention and improvement of symptomatic COVID-19.
- 2024-09-03
- RCT · n = 228
- Scientific reports 14(1)
- Huan Wang
- Liyuan Tao
- Liyan Cui
- Yahong Chen
- Dongyang Liu
- Lixiang Xue
- Yuping Yang
- Yang Lv
- Fuchun Zhang
- Tiancheng Wang
- Xiaoxiao Wang
- Wanqiong Yuan
- Hao Liu
- Jie Huang
- Yanfang Jiang
- Na Liu
- Lijuan Yang
- Yunjing Hu
- Yanfang Li
- Yuling Gao
- Haiyan Li
- Baohua Li
- Chunli Song
- PubMed: 39227626
- DOI: 10.1038/s41598-024-66267-8
- High evidence
- Large Human Trial
- Rigorous Journal
- Clinical
According to the second level of vitamin D, there was a 14.3% difference in positive infection rates between the vitamin D adequate (> 30 ng/mL) and deficient groups (< 20 ng/mL). Adequate vitamin D had a tendency to prevent COVID-19.
- Effect
- Neutral
- Effect size
- Moderate
- Significant
- No